Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medical Devices
Safety Information
Safety communications
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
COVID-19 Updates
Our role
Safety Information
Reporting safety issues
Monitoring device safety
Safety communications
About HPRA Safety Notices
Manufacturer's Field Safety Notices
User Engagement
Consumer advice
Regulatory Information
Registration
Medical Devices News & Events
Special Topics
Contact Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Paradigm Insulin Infusion Pump. Priority 2 – Warning
Notice type:
Warning
Date:
24/04/2014
Product name or type:
Paradigm Insulin Infusion Pump. Priority 2 – Warning
Reference:
SN2014(20)
Manufacturer Or Supplier:
Medtronic MINIMED
Target Audience:
All Hospital Staff
All Nursing Home Staff
A&E Departments
Ambulance Service
Cardiology Departments
Cardiothoracic Departments
Carers
Chief Executive Officers
Clinical Directors
Day Surgery Units
Emergency Medical Technicians
Diabetic Clinics/ outpatients
Diabetic nurse specialists
Diabetic departments
Endocrinology units
Endocrinology Consultants
Gastroenterology Departments
General Practitioners
General Public
Haemodialysis Units
Healthcare professionals who use these devices
Healthcare professionals managing patients who use these devices
High Dependency Units
Hospital Managers
Hospital Pharmacists
Intensive Care Units
IV Nurse Specialists
Maternity Units
Midwifery Departments
Neonatology Departments
Nursing Managers
Nursing staff
Obstetrics and Gynaecology Departments
Oncology Nurse Specialists
Paediatric Departments
Paramedics
Peritoneal Dialysis Units
Purchasing / Procurement / Material Managers
Renal Medicines Departments
Resuscitation Officers
Risk Managers
Supplies Managers
Theatre Managers and nurses
Urology Departments
Problem Or Issue:
Medtronic has received a number of reports regarding users who have accidentally programmed the pump to deliver the maximum bolus amount, including one incident that resulted in severe hypoglycaemia.
All insulin delivery programmed through the Main Menu will allow the down arrow button to scroll from 0.0 units to the programmed maximum bolus insulin dose.
Background Information Or Related Documents:
Paradigm Insulin Infusion Pump. Priority 2 – Warning Document
This action applies to Paradigm Pump models MMT-511, MMT-512, MMT-712, MMT-712E, MMT-515, MMT-715, MMT-522, MMT-522K, MMT-722, MMT-722K, MMT-523, MMT-523K, MMT-723, MMT-723K, MMT-554, and MMT-754.
When using the Express Bolus button to deliver a bolus, the down arrow will scroll to 0.0 units and stop.
Because accidental button pressing errors may occur, it is important that patients always confirm the insulin dose flashing on the display is correct before pressing ACT to start delivery.
The IMB is working with Medtronic and the HSE to ensure awareness of this issue.
Actions To Be Taken:
The IMB advise that users:
(1) Follow the instructions outlined by the manufacturer in the field safety notice (FSN) attached.
(2) When programming insulin doses through the Main Menu, pay close attention because scrolling down allows the dose displayed on the screen to go from 0.0 units to the maximum programmed insulin dose.
(3) Always confirm the insulin dose flashing on the display is correct before pressing ACT to start delivery.
(4) The Max Bolus and Max Basal safety limits should be programmed in your patients’ pumps according to their individual insulin needs.
(5) Forward this IMB Safety Notice to all those within your organisation that need to be aware of this information. Please also pass this Safety Notice and the attached FSN on to any end users or organisations where these devices may have been distributed.
Further Information:
Enquiries to the
manufacturer
should be addressed to:
Medtronic MINIMED
18000 Devonshire Street
CA 91325 -1219
Northridge
USA
Telephone: +1 818 576 5555
Fax: +1 818 365 2246
E-mail: N/A
Website: N/A
Enquiries to the
distributor
should be addressed to:
Medtronic Limited
Building 9 Croxley Green Business Park
WD18 8WW
Watford
United Kingdom
Telephone: +44 1923 212213
Fax: N/A
E-mail:
vigilance.eu@medtronic.com
Website: N/A
All
adverse incidents
relating to a medical device should be reported to:
Health Products Regulatory Authority
Human Products Monitoring
Kevin O’Malley House
Earlsfort Centre
Earlsfort Terrace
Dublin 2
Telephone: +353-1-6764971
Fax: +353-1-6344033
E-mail:
devicesafety@hpra.ie
Website:
www.hpra.ie
Please click here to view a PDF version of this safety notice
Please click here to view a copy of FSN 1
Please click here to view a copy of FSN 2
« Back
Date Printed: 02/05/2024